Zofia E. Dziewanowska

2008

In 2008, Zofia E. Dziewanowska earned a total compensation of $647.2K as Vice President, Clinical Research and Regulatory at Ligand Pharmaceuticals, a 5% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$99,840
Option Awards$138,267
Salary$332,800
Stock Awards$67,434
Other$8,858
Total$647,199

Dziewanowska received $332.8K in salary, accounting for 51% of the total pay in 2008.

Dziewanowska also received $99.8K in non-equity incentive plan, $138.3K in option awards, $67.4K in stock awards and $8.9K in other compensation.

Rankings

In 2008, Zofia E. Dziewanowska's compensation ranked 5,705th out of 9,135 executives tracked by ExecPay. In other words, Dziewanowska earned more than 37.5% of executives.

ClassificationRankingPercentile
All
5,705
out of 9,135
38th
Division
Manufacturing
2,086
out of 3,436
39th
Major group
Chemicals And Allied Products
441
out of 815
46th
Industry group
Drugs
284
out of 597
52nd
Industry
Pharmaceutical Preparations
210
out of 408
49th
Source: SEC filing on April 29, 2009.

Dziewanowska's colleagues

We found four more compensation records of executives who worked with Zofia E. Dziewanowska at Ligand Pharmaceuticals in 2008.

2008

John Higgins

Ligand Pharmaceuticals

Chief Executive Officer

2008

Martin Meglasson

Ligand Pharmaceuticals

Vice President, Discovery Research

2008

John Sharp

Ligand Pharmaceuticals

Chief Financial Officer

2008

Charles Berkman

Ligand Pharmaceuticals

General Counsel

You may also like